Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Antiphospholipid antibodies and malignancy.

Chi Pham1, Yu-Min Shen

  • 1The University of Texas Southwestern Medical Center at Dallas, 5323 Harry Hines Boulevard, Dallas, TX 75390-8852, USA.

Hematology/Oncology Clinics of North America
|January 22, 2008
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

Gastritis-II: Pathophysiology01:17

Gastritis-II: Pathophysiology

Gastritis is marked by disruption of the mucosal barrier that usually protects the stomach tissue from digestive juices and manifests in acute and chronic forms.
In acute gastritis, the gastric mucosa becomes swollen and red and undergoes superficial erosion. Superficial ulceration may lead to bleeding.
In chronic gastritis, persistent or repeated insults lead to chronic inflammatory changes and, eventually, thinning or atrophy of the gastric tissue.
Gastritis can stem from various causes, each...
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Using Preoperative Therapeutic Plasma Exchange in Lupus Anticoagulant Hypoprothrombinemia Syndrome to Achieve Hemostatic Factor II Activity: A Case Report.

Journal of clinical apheresis·2026
Same author

Potential Adjunctive Role of Osteopathic Manipulative Medicine in the Management of Cancer-Related Bone Pain: A Narrative Review.

Cureus·2026
Same author

Emicizumab in the treatment of acquired hemophilia A: A Two-Center experience.

Annals of hematology·2026
Same author

Differential gene regulation by SR12813 and rifampicin: Insights into PXR and PPARγ activation and metabolic pathway modulation in LS180 colon cancer cells.

Drug metabolism and disposition: the biological fate of chemicals·2026
Same author

Engineering Doping and Vacancy in a C<sub>3</sub>N<sub>4</sub> Electrocatalyst with Ni<sub>4</sub>Mo Cocatalyst for Efficient Alkaline Hydrogen Evolution.

ACS omega·2026
Same author

Management of splanchnic venous thrombosis after splenectomy in hematologic diseases. systematic review, meta-analysis and consensus guidelines.

International journal of surgery (London, England)·2025

Antiphospholipid antibody syndrome (APS) can cause blood clots and pregnancy complications. This review details the link between APS, cancer prevalence, and patient outcomes.

Area of Science:

  • Rheumatology
  • Hematology
  • Obstetrics & Gynecology

Background:

  • Antiphospholipid antibody syndrome (APS) is an autoimmune disorder.
  • Clinical manifestations include thrombosis (venous or arterial) and pregnancy morbidity (recurrent fetal loss, placental insufficiency).

Purpose of the Study:

  • To describe the prevalence of malignancy in patients with APS.
  • To outline the clinical manifestations of APS.
  • To discuss the prognosis for individuals diagnosed with APS.

Main Methods:

  • Literature review of studies on Antiphospholipid antibody syndrome.
  • Analysis of data regarding malignancy prevalence in APS patients.
  • Synthesis of information on clinical features and outcomes.

Related Experiment Videos

Main Results:

  • Malignancy is a significant consideration in the differential diagnosis and management of APS.
  • APS presents with a spectrum of thrombotic and obstetric complications.
  • Prognosis is influenced by factors such as thrombosis recurrence, malignancy, and adherence to treatment.

Conclusions:

  • Understanding the association between APS and malignancy is crucial for comprehensive patient care.
  • Early diagnosis and management of APS can improve patient outcomes.
  • Further research is warranted to elucidate the complex interplay between APS, thrombosis, and cancer.